An Efficacy and Safety Study of Decitabine in Participants With Myelodysplastic Syndrome (MDS)

Summary

The purpose of this study is to evaluate the response rate of decitabine in previously treated and untreated Taiwanese participants with Myelodysplastic Syndrome (MDS - a disease associated with decreased production of blood cells, blood cells are produced but do not mature normally).

Timeline

Start

2008-08

Primary completion

2010-09

Completion

2012-08

Drugs

Indications